292 related articles for article (PubMed ID: 21832831)
1. Birch-apple syndrome treated with birch pollen immunotherapy.
Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
[TBL] [Abstract][Full Text] [Related]
2. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
[TBL] [Abstract][Full Text] [Related]
3. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
4. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
Bucher X; Pichler WJ; Dahinden CA; Helbling A
Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
[TBL] [Abstract][Full Text] [Related]
5. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
7. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1.
Kinaciyan T; Jahn-Schmid B; Radakovics A; Zwölfer B; Schreiber C; Francis JN; Ebner C; Bohle B
J Allergy Clin Immunol; 2007 Apr; 119(4):937-43. PubMed ID: 17204315
[TBL] [Abstract][Full Text] [Related]
8. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
9. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.
Mauro M; Russello M; Incorvaia C; Gazzola GB; Di Cara G; Frati F
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):119-22. PubMed ID: 17523385
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
12. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
13. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
14. [Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity].
Modrzyński M; Zawisza E; Rapiejko P; Przybylski G
Przegl Lek; 2002; 59(12):1007-10. PubMed ID: 12731377
[TBL] [Abstract][Full Text] [Related]
15. Effect of hyposensitization for tree pollinosis on associated apple allergy.
Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L
J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432
[TBL] [Abstract][Full Text] [Related]
16. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
17. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.
Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK
J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921
[TBL] [Abstract][Full Text] [Related]
18. Allergen immunotherapy for birch-apple syndrome: what do we know?
Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B
Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
